BBK Worldwide Blog

BBK's patient recruitment campaign for Parkinson's disease has been selected as a finalist for the Pharmaceutical Executive APEX Awards

It's exciting times here at BBK! We are so thrilled to be recognized for our creative work on the Cerevel TemPo Studies website; developed to inform and prescreen patients newly diagnosed with Parkinson’s disease. We've been selected as a finalist for this year’s Pharmaceutical Executive APEX Awards — the only healthcare marketing awards judged entirely by HCPs. 

We recently sat down with BBK’s Global Strategist Amanda Moody to discuss the company’s commitment to Parkinson’s disease clinical research, including ongoing innovation designed to foster a positive and meaningful patient journey. 

Can you briefly describe BBK’s experience with the Parkinson’s disease community?

We have a long-standing commitment to the Parkinson’s community, both in terms of supporting clinical research as well as individual patient and caregiver needs. 

Sharing in the commitment to advance research and knowledge for the Parkinson’s disease community, BBK Worldwide is proud to support the 2021 Parkinson’s Disease Therapeutics Webinar Series, hosted by The Michael J. Fox Foundation.

This free online series brings together Parkinson’s researchers, drug developers, and clinicians to discuss new findings and trending topics in Parkinson’s research and development.